LYMPHOMA BIOLOGY

Poster number

Title

Submitting author

City and Country

89

Clinical impact of T-cell receptor repertoire diversity in patients with lymphoma undergoing autologous stem cell transplantation

Gustav Jørgensen

Copenhagen, Denmark

90

Baseline circulating tumour DNA and total metabolic tumour volume as early outcome predictors in aggressive B-cell lymphoma. A real life prospective 112-patient cohort.

Marie-Hélène Delfau Larue

Creteil, France

91

Circulating tumor DNA load and total metabolic tumor volume in Diffuse Large B Cell Lymphoma (DLBCL) patients treated by R-CHOP – From REMARC, A LYSA study

Elodie BOHERS

Rouen, France

92

High risk aggressive B-cell lymphoma on the liquid biopsy

Leo Meriranta

Helsinki, Finland

93

Immune and Virus-specific Responses in Participants with Primary Effusion Lymphoma Receiving Lenalidomide, Dose-adjusted EPOCH, and Rituximab (EPOCH-R2)

Kathryn Lurain

Bethesda, MD, USA

94

Clinical Responses to Odronextamab (REGN1979): Correlation with Loss of CD20 Expression as a Potential Mechanism of Resistance and Baseline Biomarkers of Tumor T cells

Jurriaan Brouwer-Visser

Tarrytown, NY, USA

95

Highly Multiplex Tissue Imaging of DLBCL Identifies Novel Pathological Features Predictive of Overall Survival

Dylan McNally

New York, NY, USA

96

Digital Spatial Profiling of Diffuse Large B-Cell Lymphomas reveals STING as an immune-related determinant of survival after R-CHOP therapy

Claudio Tripodo

Palermo, Italy

97

MYC, BCL2 and BCL6 coexpression patterns at single-cell resolution re-define double expressor lymphomas

Anand Jeyasekharan

Singapore, Singapore

98

Nanostring analysis of Mycosis Fungoides offers clues to better understand MF pathogenesis and progression

Ruth Alonso-Alonso

Madrid, Spain

99

9p gain predicts outcomes in patients with relapsed/refractory (R/R) diffuse large B-cell lymphoma (DLBCL) treated with R-GemOx +/- Atezolizumab. ARGO: A randomised phase II study

Andy Davies

Southampton, UK

100

Molecular High Grade (MHG) gene expression profile in DLBCL is enriched among patients with early treatment failure

Sharon Barrans

Leeds, UK

101

Characterization of the genetic landscape of high-grade B-cell lymphoma, NOS – an LLMPP project

Brett Collinge

Burnaby, Canada

102

RNA sequencing reveals different gene expression in male versus female diffuse large B-cell lymphoma.

Paola Ghione

Buffalo, NY, USA

103

Testicular diffuse large B-cell lymphoma: clinico-biological characterization, evaluation of treatment response and survival

Alfredo Rivas-Delgado

Barcelona, Spain

104

A GENE SIGNATURE TO PREDICT RISK OF TRANSFORMATION IN PATIENTS WITH FOLLICULAR LYMPHOMA

Ismael Fernandez-Miranda

Majadahonda, Spain

105

Mutational landscape of marginal zone B-cell lymphomas of various origin: organotypic alterations and diagnostic potential for assignment of organ origin

Stefan Dirnhofer

Basel, Switzerland

106

Cytidine deaminases shape the genome of germinal center B cell derived lymphoma

Meiqi Ren

Heidelberg, Germany